Loading
Latest filing published 16 Nov 2021 for Jounce Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Cary Pfeffer across 2 companies, led by Jounce Therapeutics, Inc. and Neon Therapeutics, Inc. The record holds 13 filings, for trades running from 1 February 2017 to 12 November 2021.
No open-market purchase appears, only 4 sales. The totals do not cover 4 filings with an undisclosed amount. In 2021 alone, the filings show no purchases and 2 sales.
The newest entry dates from 16 November 2021: an open-market sale, in Jounce Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations